AS

Ashok Singh

Active Director Director DIN 01421247
DIN 01421247 First appointment Apr 1995 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Apr 1995
Shareholding value •••• Premium profile

About Ashok Singh

Data last updated:

Ashok Singh is a Director at Excellar Healthcare Private Limited (since 2007), Director at Pelfizz Biotech Private Limited (since 2004) and Director at Excell Formulations Private Limited (since 1995), and holds 1 more current directorship. The companies operate in Agriculture and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹55.65 Cr; the largest is Excellar Healthcare Private Limited at ₹45.80 Cr (FY 2025). Earlier, Ashok Singh was an Additional Director at Varun Medico Lab Private Limited (2002–2012).

DIN 01421247
Primary Designation Director
Industry Agriculture
First Appointment 18 Apr 1995
Oldest Company Age 31 yrs
Largest company Excellar Healthcare Private Limited · ₹45.80 Cr (FY 2025)
Combined revenue ₹55.65 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Excellar Healthcare Private Limited U24239MH2007PTC168852
Director16 Mar 20072007₹45.80 Cr (FY 2025)Active
Pelfizz Biotech Private Limited U24230MH2004PTC146186
Director10 May 20042004₹9.77 Cr (FY 2024)Active
Excell Formulations Private Limited U24230MH1995PTC087403
Director18 Apr 19951995₹8.6 Lakh (FY 2025)Active
Director18 Jun 20022002Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Varun Medico Lab Private Limited U24239MH1996PTC099594
Additional Director27 Mar 20021996₹1.44 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Excell Formulations Private Limited
Pelfizz Biotech Private Limited
Excellar Healthcare Private Limited
Aahar Associates (India) Private Limited
Premium access

Shareholding and investment profile for Ashok Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Singh

Ashok Singh currently holds 4 directorships: Excellar Healthcare Private Limited (Director, since 16 Mar 2007, revenue ₹45.80 Cr (FY 2025)); Pelfizz Biotech Private Limited (Director, since 10 May 2004, revenue ₹9.77 Cr (FY 2024)); Excell Formulations Private Limited (Director, since 18 Apr 1995, revenue ₹8.6 Lakh (FY 2025)); Aahar Associates (India) Private Limited (Director, since 18 Jun 2002).

Ashok Singh was first appointed on 18 Apr 1995 as Director at Excell Formulations Private Limited. The most recent appointment on record is 16 Mar 2007 at Excellar Healthcare Private Limited.

The 3 current companies of Ashok Singh that report revenue have a combined latest revenue of ₹55.65 Cr: Excellar Healthcare Private Limited ₹45.80 Cr (FY 2025); Pelfizz Biotech Private Limited ₹9.77 Cr (FY 2024); Excell Formulations Private Limited ₹8.6 Lakh (FY 2025).

Ashok Singh held 1 earlier board appointment: Varun Medico Lab Private Limited (Additional Director, 27 Mar 2002 to 21 Apr 2012).

The current boards of Ashok Singh's companies include Bhaskar Chaudhuri (Excellar Healthcare Private Limited), Hemant Vasudeo Hajare (Excellar Healthcare Private Limited), Himanshu Kumar (Excellar Healthcare Private Limited), Kausik Chakraborty (Excellar Healthcare Private Limited), Kalapana Hemant Hajare (Pelfizz Biotech Private Limited), Neelam Ashok Singh (Pelfizz Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available